Fazal Hadi | Pharmaceutical Sciences | Best Researcher Award

Published on by Global Academic Awards

Dr. Fazal Hadi | Pharmaceautical sciences | Best Researcher Award

Dr. Fazal Hadi, Abdul Wali Khan University Mardan, Pakistan

Dr. Fazal Hadi is a dedicated hospital pharmacist and emerging researcher from Mardan, Pakistan. Currently pursuing his PhD in Pharmaceutical Sciences at AWKUM, he specializes in pharmacology, phytochemistry, and drug interaction studies. With hands-on experience as a pharmacist at MERF hospitals and academic roles as a visiting lecturer and research assistant, Dr. Hadi blends practical expertise with academic excellence. He has authored multiple publications in reputed journals and actively participates in scientific conferences. Fluent in Pashto, Urdu, and English, he is passionate about improving patient care through innovative pharmaceutical research.

Publication Profile

Orcid

Google Scholar

🧪 Professional Experience

Dr. Fazal Hadi brings extensive pharmaceutical and academic experience to his role in healthcare and research. As a Visiting Lecturer at AWKUM (2025–present), he engages students with lectures and guides scholarly work. From 2022–2024, he worked as a Research Assistant, mastering techniques like PCR, RNA extraction, and in vivo assays. Concurrently, he served as a Pharmacist at MERF hospitals in Peshawar, ensuring drug stock management and patient care. Earlier roles include service at a COVID-19 hospital and GIK Institute. His leadership as Pharmacy Store In-Charge during the “Sihat ka Insaaf” campaign in 2015 further highlights his dedication.

🎓 Educational Background

Dr. Fazal Hadi has pursued a progressive academic journey in pharmaceutical sciences. He is currently enrolled in a Ph.D. in Pharmaceutical Sciences at AWKUM, Mardan (2026, in progress) 🧪. He completed his MPhil in Pharmacology from Abasyn University, Peshawar in 2019 with a CGPA of 3.27/4 📊. He earned his Doctor of Pharmacy (Pharm D) from Gandhara University, Peshawar in 2014 with First Division 💊. Additionally, he holds a Bachelor of Arts in Sociology from AWKUM (2011) and completed FSc (Pre-medical) at Islamia College, Peshawar (2008, A+ grade) and Matriculation in Science in 2006 with an A1+ grade

🔬 Research Focus

Dr. Fazal Hadi’s research primarily revolves around pharmacology, ethnopharmacology, and natural product chemistry 🌿. His work emphasizes the therapeutic potential of medicinal plants, focusing on their analgesic, antipyretic, anthelmintic, antidiabetic, and nutritional properties 🌱🧬. He also investigates food–drug interactions, as shown in his pharmacokinetics research on grape juice and omeprazole 🥤💊. His studies bridge traditional medicine with modern pharmacological validation, contributing to safe and effective drug discovery. By integrating in vivo, in vitro, and molecular techniques, his research supports innovation in herbal medicine, clinical pharmacy, and pharmaceutical sciences

Publication Top Notes

📄 “Integrating In Vitro, Network Pharmacology, and Molecular Docking Approaches to Uncover the Antidiabetic Potential of Tylophora hirsuta“ – Computational Biology and Chemistry, 2025 
📄 “Unveiling the Therapeutic and Nutritious Potential of Vigna unguiculata in Line with its Phytochemistry” – Heliyon, 2024 | Cited by: 10 🌱🧬
📄 “Vigna mungo (Linn.) Hepper: Ethnobotanical, Pharmacological, Phytochemical, and Nutritious Profile” – Phytochemistry Reviews, 2024 | Cited by: 1 🌿📚
📄 “In Vivo Investigations of Analgesic, Antipyretic and Anthelmintic Activities of Various Extracts of Fernandoa adenophylla“ – Pharmaceutical Chemistry Journal, 2021 | Cited by: 4 🧫💊
📄 “Impact of Fresh Grape Juice on the Pharmacokinetics of Omeprazole: Results of a Food–Drug Interaction Study” – Frontiers in Pharmacology, 2024

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Published on by Global Academic Awards

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. 🧑‍🔬👩‍🏫🔬

Publication Profile

Google Scholar

Work Experience 🌍💼

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. 📚🌐👩‍🔬

 

Qualifications 🎓🌟

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. 🧪📘👩‍🔬

 

Additional Experience 🌍🔬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. 📚💡📈

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry 💊. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials 🏗️, photocatalysis ⚛️, and nanomaterials 🧪 with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design 💻, enzyme inhibition 🧪, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes  

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) 🔋
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) 💊
  • Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) 💡
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) 🔬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) 💧
  • The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase (28 citations, 2017) 🧪
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Anand Kumar | Pharmaceutical Science | Best Researcher Award

Published on by Global Academic Awards

Mr. Anand Kumar | Pharmaceutical Science | Best Researcher Award

Mr. Anand Kumar, Babasaheb Bhimrao Ambedkar University Lucknow, India

🎓 Dr. Anand Kumar is a dedicated researcher and educator with a profound academic background. He holds a Ph.D. in Pharmaceutical Sciences, specializing in areas like Cancer Biology, Muscle Biology, and Sarcopenia. An alumnus of prestigious institutions such as Babasaheb Bhimrao Ambedkar University and Chhatrapti Shahu Ji Maharaj University, Dr. AnandKumar has been honored with fellowships from Indian Council of Medical Research and University Grants Commission. His commitment to advancing pharmaceutical knowledge is underscored by his multiple qualifications and extensive research experience. With a passion for understanding and combating diseases, he represents a beacon of excellence in the field. 🏅

Publication Profile:

Orcid

Google Scholar

Education Qualifications:

🎓 Dr. AnandKumar’s educational journey is marked by a series of impressive accomplishments and a steadfast pursuit of excellence in pharmaceutical sciences. His academic odyssey began with an Intermediate degree in Physics, Chemistry, and Maths from the UP Board, where he attained a commendable first-class score. Venturing further into the realm of pharmacy, he obtained a D. Pharm from Sarojini Naidu Medical College, Agra, demonstrating his early dedication to the field. Undeterred by challenges, he pursued a B. Pharm from Chhatrapti Shahu Ji Maharaj University, Kanpur, and later, an M. Pharm in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where he consistently achieved first-class distinctions.His academic journey culminated in a significant milestone with a Ph.D. in Pharmaceutical Sciences from the same institution, where his thesis was submitted in July 2023. Dr. AnandKumar’s relentless pursuit of knowledge and his commitment to academic excellence are evident in his consistent academic achievements. Through his rigorous academic training, he has honed his expertise in areas such as pharmacology and pharmaceutical sciences, paving the way for impactful contributions to the field. Dr. AnandKumar’s educational trajectory exemplifies resilience, dedication, and a profound passion for advancing pharmaceutical research and practice. 🌟

Honors, Recognition, and Awards:

🏅 Dr. AnandKumar’s contributions to pharmaceutical research have been recognized through prestigious honors and awards. In 2022, he was bestowed with the Indian Council of Medical Research (ICMR) Senior Research Fellowship (SRF) by the Ministry of Health and Family Welfare, Government of India, acknowledging his exceptional research prowess. Prior to this, he received the PGSPROF Fellowship from the University Grants Commission (UGC) between 2016 and 2018, further affirming his dedication to academic excellence. Additionally, Dr. AnandKumar’s exemplary performance is underscored by his remarkable achievement of qualifying the Graduate Pharmacy Aptitude Test (GPAT) five times between 2017 and 2023, highlighting his commitment to continuous learning and proficiency in pharmaceutical sciences. 🌟

Professional Experience:

👨‍🏫 Dr. AnandKumar’s professional journey includes both teaching and research experiences, shaping him into a well-rounded pharmaceutical scientist. His teaching tenure spans six months, during which he imparted knowledge and mentored students in various aspects of pharmacy. Complementing his role in academia, Dr. AnandKumar has amassed valuable research experience in diverse domains. Through his engagement in research, he has delved into intricate subjects such as Cancer Biology, Muscle Biology, and Sarcopenia, contributing significantly to the advancement of pharmaceutical sciences. His dual expertise in teaching and research reflects his commitment to academic excellence and his passion for pushing the boundaries of scientific inquiry. 📚🔬

Research Focus:

🔬 Dr. Anand Kumar’s research focus encompasses a broad spectrum of pharmaceutical sciences, with a particular emphasis on combating various aspects of muscle biology-related disorders. His work delves into elucidating mechanisms underlying skeletal muscle wasting conditions such as sarcopenia, diabetic muscle atrophy, and muscle damage induced by diverse factors. Through innovative approaches including pharmacological interventions and targeted drug delivery systems, he aims to mitigate muscle wasting and associated inflammatory responses. Dr. AnandKumar’s multidisciplinary research endeavors, as evidenced by his publications, contribute significantly to understanding and addressing the complexities of muscle-related pathologies, paving the way for novel therapeutic strategies in the field. 🌟

Publication Top Notes:

Novel synergistic approach: tazarotene-calcipotriol-loaded-PVA/PVP-nanofibers incorporated in hydrogel film for management and treatment of psoriasis

Azilsartan Ameliorates Skeletal Muscle Wasting in High Fat Diet (HFD)-induced Sarcopenic Obesity in Rats via Activating Akt Signalling Pathway

Salbutamol ameliorates skeletal muscle wasting and inflammatory markers in streptozotocin (STZ)-induced diabetic rats

Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines

Salbutamol Attenuates Diabetic Skeletal Muscle Atrophy by Reducing Oxidative Stress, Myostatin/GDF-8, and Pro-Inflammatory Cytokines in Rats

Atenolol Ameliorates Skeletal Muscle Atrophy and Oxidative Stress Induced by Cast Immobilization in Rats

Evaluation Of Azilsartan Transdermal Hydrogel In Volumetric Muscle Loss Injury In A Rat Model

Investigating the Role of Angiotensin Receptor Blockers (ARBs) In High Fat Diet-Induced Sarcopenic Rats Associated Muscle Wasting

Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma